Skip to main content
Premium Trial:

Request an Annual Quote

Canada's Budget Seeks C$165M for Genome Canada

NEW YORK (GenomeWeb News) – Genome Canada is poised to receive C$165 million (US$161 million) over the next three years to fund its genomics and life sciences research programs and to execute its long-term strategies, under the Department of Finance's new budget plan.

The new funding from the 2013 Economic Action Plan, which Finance Minister Jim Flaherty provided to the House of Commons late last week, would support Genome Canada's operations in fiscal years 2014 and 2015, but also would allow some funds to be spent earlier or later, based on the strategic plan.

The funding proposal would increase Genome Canada's federal support, which was C$65 million in 2011 and C$60 million in 2012, although how much of an increase will depend on how the money will be spread out between 2013 and 2015.

The 2013 budget also will award C$225 million to fund advanced research infrastructure projects and long-term operations at the Canada Foundation for Innovation.

It also provides C$60 million over five years for a Venture Capital Action Plan, which funds business incubators and accelerators and will establish a new awards program to recognize entrepreneurial excellence.

In addition, the funding plan marks C$37 million for the government granting councils to use to fund research partnerships with industry to help move new technologies toward commercialization, C$20 million over three years to help small and medium-sized enterprises access research and development services, and C$325 million over eight years to a program called Sustainable Development Technology Canada that will develop and demonstrate new clean technologies.

The funding for Genome Canada will fuel the launch of new large-scale research competitions, support the participation of Canadian genomics researchers in national and international partnership programs, and maintain the operations of Genome Canada and regional Genome Centres and Science and Technology Innovation Centres into 2017.

Genome Canada has now received over C$1 billion in government funding, and it has raised an additional C$1 billion from other partners, according to the Department of Finance.

The department also estimated that when Genome Canada's budget is combined with an additional C$280 million in matching contributions from its research partners, the amount it will have spent on genomics research will total C$2.5 billion by the end of 2017.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.